Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05236153 · ClinicalTrials.gov registry record · NA
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
A NA study, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05236153 is a NA study that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 60 participants.
The verdict
NCT05236153, a NA study, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Individuals with repaired Tetralogy of Fallot (rTOF) remain at risk for sudden cardiac death from ventricular tachycardia (VT). Transcatheter pulmonary valve replacement (TPVR) indications continue to broaden, yet its capability to reduce the risk of VT and sudden cardiac death remains unknown. Thus, in a cohort of participants with rTOF who are presenting for TPVR the investigators intend to: (1) quantify and localize right ventricular (RV) isthmuses with abnormal voltage and/or conduction velocity; (2) identify which RV isthmuses are at risk of being "jailed" by TPV prostheses; and (3) explore the feasibility of omnipolar technology to characterize wavefront directionality and differentiate slow conduction from conduction block.
Interventions
- DIAGNOSTIC_TEST Electroanatomic substrate mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-11-04 |
| Est. Completion | 2024-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05236153
The ClinicalTrials.gov registry entry for NCT05236153 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electroanatomic substrate mapping is the first listed.
NCT05236153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05236153 about?
NCT05236153 is a clinical study titled "Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot". Individuals with repaired Tetralogy of Fallot (rTOF) remain at risk for sudden cardiac death from ventricular tachycardia (VT). Transcatheter pulmonary valve replacement (TPVR) indications continue to broaden, yet its capability to reduce the risk of VT and sudden cardiac death remains unknown. Thus...
What is the current status of trial NCT05236153?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-11-04. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT05236153?
The interventions under investigation include: Electroanatomic substrate mapping (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05236153?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.